Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.

Matetzky, Shlomi

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. [electronic resource] - Circulation Jun 2004 - 3171-5 p. digital

Publication Type: Comparative Study; Journal Article

1524-4539

10.1161/01.CIR.0000130846.46168.03 doi


Adenosine Diphosphate--antagonists & inhibitors
Aged
Aspirin--administration & dosage
Biotransformation
Clopidogrel
Combined Modality Therapy
Coronary Artery Disease--complications
Coronary Restenosis--epidemiology
Coronary Thrombosis--epidemiology
Drug Resistance
Drug Therapy, Combination
Epinephrine--administration & dosage
Eptifibatide
Female
Follow-Up Studies
Humans
Male
Middle Aged
Myocardial Infarction--drug therapy
Peptides--therapeutic use
Platelet Aggregation--drug effects
Platelet Aggregation Inhibitors--pharmacology
Prodrugs--pharmacology
Prospective Studies
Purinergic P2 Receptor Antagonists
Recurrence
Risk
Smoking--epidemiology
Stents
Ticlopidine--analogs & derivatives
Treatment Outcome